You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic BCR-ABL positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2022

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis
        Nov 20, 2023

        According to Molecular Identification at Diagnosis

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Next Generation Sequencing (DNA and RNA)
        • (no location specified)
        Oct 28, 2022

        Chronic Myeloid Leukemia Trial in Jena (Venetoclax)

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Jena, Germany
          Universitätsklinikum Jena
        Jan 17, 2023

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

        Recruiting
        • Myeloproliferative Neoplasm
        • +2 more
        • Online Mindfulness Meditation
        • Internet-Based Webinars
        • San Francisco, California
          University of California San Francisco
        Aug 9, 2022

        3rd Line Therapy or More to Treat Adult CML- CP in Real World

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Oct 16, 2023

        "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

        Not yet recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
          • Sohag, Egypt
            Sohag University Hospital
          Sep 14, 2022

          Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

          Not yet recruiting
          • Chronic Myelogenous Leukemia
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          Oct 12, 2023

          Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

          Active, not recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Jena, Germany
              University Hospital Jena
            Jan 17, 2023

            Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

            Completed
            • Leukemia
            • No Intervention
            • Cambridge, Massachusetts
              Takeda
            Feb 28, 2023

            Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

            Active, not recruiting
            • Acute Lymphoblastic Leukemia
            • +11 more
            • Health Promotion and Education
            • +3 more
            • Columbus, Ohio
              Ohio State University Comprehensive Cancer Center
            Jul 24, 2023

            Ponatinib in CML Patients in Chronic Phase

            Recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
            • Therapeutic drug monitoring
            • Molecular Response
            • Cagliari, Italy
            • +4 more
            Nov 3, 2023

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023

            Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

            Recruiting
            • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • +7 more
            • Blinatumomab
            • +3 more
            • Houston, Texas
              M D Anderson Cancer Center
            Dec 31, 2022

            Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

            Recruiting
            • Acute Myeloid Leukemia
            • +4 more
            • Recombinant Interleukin-7
            • Houston, Texas
              M D Anderson Cancer Center
            Jan 26, 2023

            Chronic Myeloid Leukemia Trial (Asciminib)

            Available
            • Chronic Myeloid Leukemia
            • (no location specified)
            Jan 17, 2023

            Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

            Not yet recruiting
            • Tyrosine Kinase Inhibitors
            • Chronic Myeloid Leukemia
            • treatment of TKI in CML
            • Poitiers, France
              Chu Poitiers
            Feb 21, 2023

            Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

            Active, not recruiting
            • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • +6 more
            • Houston, Texas
              M D Anderson Cancer Center
            Dec 2, 2022